The Psychedelics Newsletter, Issue 103

The Psychedelics Newsletter, Issue 103

No alt text provided for this image

Washington’s Senate Bill 5660

In March, the Washington State legislature passed Senate Bill 5660, directing Washington State Health Care Authority to assess the provision of psilocybin services.?

State officials have created a working group to evaluate the socioeconomic benefits of an adult-use psilocybin programme.

This working group must deliver a preliminary report on its findings to the Washington State Governor by December, with a full report submitted by the end of 2023.?

Assuming the results of the report are positive, psilocybin could be available in Washington as early as 2026.

READ MORE

No alt text provided for this image

RESEARCH INTO THE BIOSYNTHESIS OF PSILOCYBIN

With?psilocybin-producing mushrooms found worldwide, researchers at University of Plymouth?study their evolution.

READ MORE

No alt text provided for this image

DEA PROPOSES PRODUCTION QUOTAS FOR 2023

It is proposed mescaline production increases from 100 grams to 1,200 grams, and that 5-MeO-DMT synthesis doubles.

READ MORE

BUSINESS AND INVESTMENT

SCIENCE AND RESEARCH

No alt text provided for this image

The UK has been at the forefront of psychedelic research since the 20th century ~?with this present era of discovery dubbed ‘the psychedelic renaissance'.

At PSYCH Symposium, Amanda Feilding, Executive?Director at Beckley Foundation, discussed the resurgence of psychedelic science and the evolution of Beckley Foundation in a very special conversation with her son, Cosmo Feilding Mellen, CEO at?Beckley Psytech.

REGULATION AND LEGISLATION

ARTICLES OF INTEREST

要查看或添加评论,请登录

PSYCH?的更多文章

社区洞察

其他会员也浏览了